Lenticlair

BI 3720931 · Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lenticlair, covering 2026-04-14 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: A Long-term Study to Monitor the Health Status of People With Cystic Fibrosis Who Took Part in a Previous Study With BI 3720931 (Lenticlair™-ON) [Phase 1, Phase 2]

See pricing